nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—CYP3A4—bone cancer	0.557	1	CbGaD
Pergolide—HTR1B—dura mater—bone cancer	0.0177	0.179	CbGeAlD
Pergolide—HTR1D—dura mater—bone cancer	0.0171	0.173	CbGeAlD
Pergolide—DRD5—eyelid—bone cancer	0.0168	0.17	CbGeAlD
Pergolide—HTR1B—trigeminal nerve—bone cancer	0.0076	0.0769	CbGeAlD
Pergolide—HTR1D—trigeminal nerve—bone cancer	0.00736	0.0744	CbGeAlD
Pergolide—HTR1B—cranial nerve—bone cancer	0.00541	0.0548	CbGeAlD
Pergolide—HTR1D—cranial nerve—bone cancer	0.00524	0.053	CbGeAlD
Pergolide—HTR2A—trigeminal nerve—bone cancer	0.00365	0.037	CbGeAlD
Pergolide—HTR2A—cranial nerve—bone cancer	0.0026	0.0263	CbGeAlD
Pergolide—HTR2A—vertebral column—bone cancer	0.00255	0.0258	CbGeAlD
Pergolide—HTR2A—hindlimb—bone cancer	0.00219	0.0222	CbGeAlD
Pergolide—Ergonovine—CYP3A4—bone cancer	0.002	0.3	CrCbGaD
Pergolide—HTR2A—appendage—bone cancer	0.00188	0.019	CbGeAlD
Pergolide—Methylergometrine—CYP3A4—bone cancer	0.00174	0.262	CrCbGaD
Pergolide—Cabergoline—CYP3A4—bone cancer	0.00174	0.262	CrCbGaD
Pergolide—Lisuride—CYP3A4—bone cancer	0.00117	0.176	CrCbGaD
Pergolide—HTR1D—connective tissue—bone cancer	0.00108	0.0109	CbGeAlD
Pergolide—HTR1B—spinal cord—bone cancer	0.000741	0.00749	CbGeAlD
Pergolide—HTR2C—spinal cord—bone cancer	0.00071	0.00719	CbGeAlD
Pergolide—HTR2B—tendon—bone cancer	0.000692	0.007	CbGeAlD
Pergolide—ADRA2A—connective tissue—bone cancer	0.000632	0.00639	CbGeAlD
Pergolide—HTR1A—spinal cord—bone cancer	0.000598	0.00605	CbGeAlD
Pergolide—ADRA2C—tendon—bone cancer	0.000544	0.00551	CbGeAlD
Pergolide—HTR2A—connective tissue—bone cancer	0.000537	0.00544	CbGeAlD
Pergolide—KCNH2—bone marrow—bone cancer	0.000534	0.00541	CbGeAlD
Pergolide—KCNH2—spinal cord—bone cancer	0.000532	0.00538	CbGeAlD
Pergolide—ADRA2C—spinal cord—bone cancer	0.000525	0.00531	CbGeAlD
Pergolide—ADRA2A—tendon—bone cancer	0.000434	0.0044	CbGeAlD
Pergolide—ADRA2A—spinal cord—bone cancer	0.000419	0.00424	CbGeAlD
Pergolide—HTR2A—tendon—bone cancer	0.000369	0.00374	CbGeAlD
Pergolide—HTR2A—spinal cord—bone cancer	0.000356	0.0036	CbGeAlD
Pergolide—Ataxia—Doxorubicin—bone cancer	0.000333	0.00123	CcSEcCtD
Pergolide—Dysphagia—Epirubicin—bone cancer	0.000331	0.00122	CcSEcCtD
Pergolide—Asthma—Epirubicin—bone cancer	0.000331	0.00122	CcSEcCtD
Pergolide—Influenza—Epirubicin—bone cancer	0.000331	0.00122	CcSEcCtD
Pergolide—Dysuria—Methotrexate—bone cancer	0.000331	0.00122	CcSEcCtD
Pergolide—Dehydration—Doxorubicin—bone cancer	0.00033	0.00122	CcSEcCtD
Pergolide—Paraesthesia—Cisplatin—bone cancer	0.000329	0.00121	CcSEcCtD
Pergolide—Eosinophilia—Epirubicin—bone cancer	0.000328	0.00121	CcSEcCtD
Pergolide—Liver function test abnormal—Doxorubicin—bone cancer	0.000327	0.00121	CcSEcCtD
Pergolide—Dyspnoea—Cisplatin—bone cancer	0.000327	0.00121	CcSEcCtD
Pergolide—Erectile dysfunction—Methotrexate—bone cancer	0.000326	0.0012	CcSEcCtD
Pergolide—Dry skin—Doxorubicin—bone cancer	0.000325	0.0012	CcSEcCtD
Pergolide—Pancreatitis—Epirubicin—bone cancer	0.000325	0.0012	CcSEcCtD
Pergolide—Orthostatic hypotension—Doxorubicin—bone cancer	0.000324	0.00119	CcSEcCtD
Pergolide—Hypokalaemia—Doxorubicin—bone cancer	0.000323	0.00119	CcSEcCtD
Pergolide—Angina pectoris—Epirubicin—bone cancer	0.000322	0.00119	CcSEcCtD
Pergolide—Decreased appetite—Cisplatin—bone cancer	0.000319	0.00118	CcSEcCtD
Pergolide—Bronchitis—Epirubicin—bone cancer	0.000318	0.00117	CcSEcCtD
Pergolide—Pneumonia—Methotrexate—bone cancer	0.000317	0.00117	CcSEcCtD
Pergolide—Depression—Methotrexate—bone cancer	0.000314	0.00116	CcSEcCtD
Pergolide—Gastritis—Doxorubicin—bone cancer	0.000314	0.00116	CcSEcCtD
Pergolide—Pain—Cisplatin—bone cancer	0.000313	0.00116	CcSEcCtD
Pergolide—Renal failure—Methotrexate—bone cancer	0.00031	0.00114	CcSEcCtD
Pergolide—Dysuria—Epirubicin—bone cancer	0.00031	0.00114	CcSEcCtD
Pergolide—Abdominal distension—Doxorubicin—bone cancer	0.000308	0.00114	CcSEcCtD
Pergolide—Conjunctivitis—Methotrexate—bone cancer	0.000307	0.00113	CcSEcCtD
Pergolide—Dysphagia—Doxorubicin—bone cancer	0.000306	0.00113	CcSEcCtD
Pergolide—Asthma—Doxorubicin—bone cancer	0.000306	0.00113	CcSEcCtD
Pergolide—Influenza—Doxorubicin—bone cancer	0.000306	0.00113	CcSEcCtD
Pergolide—Pollakiuria—Epirubicin—bone cancer	0.000306	0.00113	CcSEcCtD
Pergolide—Eosinophilia—Doxorubicin—bone cancer	0.000303	0.00112	CcSEcCtD
Pergolide—Sweating—Methotrexate—bone cancer	0.000302	0.00112	CcSEcCtD
Pergolide—Feeling abnormal—Cisplatin—bone cancer	0.000302	0.00111	CcSEcCtD
Pergolide—Weight increased—Epirubicin—bone cancer	0.000301	0.00111	CcSEcCtD
Pergolide—Haematuria—Methotrexate—bone cancer	0.000301	0.00111	CcSEcCtD
Pergolide—Pancreatitis—Doxorubicin—bone cancer	0.0003	0.00111	CcSEcCtD
Pergolide—Weight decreased—Epirubicin—bone cancer	0.000299	0.00111	CcSEcCtD
Pergolide—Hyperglycaemia—Epirubicin—bone cancer	0.000299	0.0011	CcSEcCtD
Pergolide—Angina pectoris—Doxorubicin—bone cancer	0.000298	0.0011	CcSEcCtD
Pergolide—Epistaxis—Methotrexate—bone cancer	0.000297	0.0011	CcSEcCtD
Pergolide—Pneumonia—Epirubicin—bone cancer	0.000297	0.0011	CcSEcCtD
Pergolide—Bronchitis—Doxorubicin—bone cancer	0.000295	0.00109	CcSEcCtD
Pergolide—Renal failure—Epirubicin—bone cancer	0.00029	0.00107	CcSEcCtD
Pergolide—Body temperature increased—Cisplatin—bone cancer	0.00029	0.00107	CcSEcCtD
Pergolide—Neuropathy peripheral—Epirubicin—bone cancer	0.000289	0.00107	CcSEcCtD
Pergolide—Jaundice—Epirubicin—bone cancer	0.000288	0.00106	CcSEcCtD
Pergolide—Conjunctivitis—Epirubicin—bone cancer	0.000287	0.00106	CcSEcCtD
Pergolide—Urinary tract infection—Epirubicin—bone cancer	0.000287	0.00106	CcSEcCtD
Pergolide—Dysuria—Doxorubicin—bone cancer	0.000286	0.00106	CcSEcCtD
Pergolide—Hepatitis—Methotrexate—bone cancer	0.000283	0.00104	CcSEcCtD
Pergolide—Sweating—Epirubicin—bone cancer	0.000283	0.00104	CcSEcCtD
Pergolide—Pollakiuria—Doxorubicin—bone cancer	0.000283	0.00104	CcSEcCtD
Pergolide—Haematuria—Epirubicin—bone cancer	0.000281	0.00104	CcSEcCtD
Pergolide—Pharyngitis—Methotrexate—bone cancer	0.000281	0.00104	CcSEcCtD
Pergolide—Weight increased—Doxorubicin—bone cancer	0.000279	0.00103	CcSEcCtD
Pergolide—Epistaxis—Epirubicin—bone cancer	0.000278	0.00103	CcSEcCtD
Pergolide—Weight decreased—Doxorubicin—bone cancer	0.000277	0.00102	CcSEcCtD
Pergolide—Sinusitis—Epirubicin—bone cancer	0.000277	0.00102	CcSEcCtD
Pergolide—Hyperglycaemia—Doxorubicin—bone cancer	0.000276	0.00102	CcSEcCtD
Pergolide—Pneumonia—Doxorubicin—bone cancer	0.000275	0.00101	CcSEcCtD
Pergolide—Visual impairment—Methotrexate—bone cancer	0.000273	0.00101	CcSEcCtD
Pergolide—Bradycardia—Epirubicin—bone cancer	0.00027	0.000996	CcSEcCtD
Pergolide—Renal failure—Doxorubicin—bone cancer	0.000268	0.000991	CcSEcCtD
Pergolide—Neuropathy peripheral—Doxorubicin—bone cancer	0.000268	0.000988	CcSEcCtD
Pergolide—Jaundice—Doxorubicin—bone cancer	0.000266	0.000982	CcSEcCtD
Pergolide—Rhinitis—Epirubicin—bone cancer	0.000266	0.00098	CcSEcCtD
Pergolide—Conjunctivitis—Doxorubicin—bone cancer	0.000265	0.00098	CcSEcCtD
Pergolide—Urinary tract infection—Doxorubicin—bone cancer	0.000265	0.00098	CcSEcCtD
Pergolide—Hepatitis—Epirubicin—bone cancer	0.000265	0.000978	CcSEcCtD
Pergolide—Eye disorder—Methotrexate—bone cancer	0.000265	0.000977	CcSEcCtD
Pergolide—Tinnitus—Methotrexate—bone cancer	0.000264	0.000974	CcSEcCtD
Pergolide—Asthenia—Cisplatin—bone cancer	0.000263	0.000971	CcSEcCtD
Pergolide—Pharyngitis—Epirubicin—bone cancer	0.000263	0.000971	CcSEcCtD
Pergolide—Sweating—Doxorubicin—bone cancer	0.000262	0.000966	CcSEcCtD
Pergolide—Oedema peripheral—Epirubicin—bone cancer	0.000261	0.000963	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—bone cancer	0.00026	0.000961	CcSEcCtD
Pergolide—Epistaxis—Doxorubicin—bone cancer	0.000258	0.000951	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—bone cancer	0.000256	0.000946	CcSEcCtD
Pergolide—Visual impairment—Epirubicin—bone cancer	0.000255	0.000942	CcSEcCtD
Pergolide—Chills—Methotrexate—bone cancer	0.000254	0.000938	CcSEcCtD
Pergolide—Diarrhoea—Cisplatin—bone cancer	0.000251	0.000926	CcSEcCtD
Pergolide—Alopecia—Methotrexate—bone cancer	0.00025	0.000923	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—bone cancer	0.00025	0.000921	CcSEcCtD
Pergolide—Eye disorder—Epirubicin—bone cancer	0.000248	0.000914	CcSEcCtD
Pergolide—Tinnitus—Epirubicin—bone cancer	0.000247	0.000912	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—bone cancer	0.000246	0.000907	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—bone cancer	0.000245	0.000905	CcSEcCtD
Pergolide—Pharyngitis—Doxorubicin—bone cancer	0.000243	0.000898	CcSEcCtD
Pergolide—Oedema peripheral—Doxorubicin—bone cancer	0.000242	0.000891	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—bone cancer	0.000241	0.000891	CcSEcCtD
Pergolide—Back pain—Methotrexate—bone cancer	0.000238	0.00088	CcSEcCtD
Pergolide—Chills—Epirubicin—bone cancer	0.000238	0.000877	CcSEcCtD
Pergolide—Arrhythmia—Epirubicin—bone cancer	0.000237	0.000874	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—bone cancer	0.000236	0.000872	CcSEcCtD
Pergolide—Alopecia—Epirubicin—bone cancer	0.000234	0.000864	CcSEcCtD
Pergolide—Vomiting—Cisplatin—bone cancer	0.000233	0.00086	CcSEcCtD
Pergolide—Rash—Cisplatin—bone cancer	0.000231	0.000853	CcSEcCtD
Pergolide—Dermatitis—Cisplatin—bone cancer	0.000231	0.000852	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—bone cancer	0.000229	0.000846	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—bone cancer	0.000229	0.000844	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—bone cancer	0.000229	0.000844	CcSEcCtD
Pergolide—Anaemia—Methotrexate—bone cancer	0.000228	0.000841	CcSEcCtD
Pergolide—Flatulence—Epirubicin—bone cancer	0.000227	0.000839	CcSEcCtD
Pergolide—Tension—Epirubicin—bone cancer	0.000226	0.000835	CcSEcCtD
Pergolide—Dysgeusia—Epirubicin—bone cancer	0.000226	0.000834	CcSEcCtD
Pergolide—Nervousness—Epirubicin—bone cancer	0.000224	0.000827	CcSEcCtD
Pergolide—Back pain—Epirubicin—bone cancer	0.000223	0.000823	CcSEcCtD
Pergolide—Malaise—Methotrexate—bone cancer	0.000222	0.00082	CcSEcCtD
Pergolide—Vertigo—Methotrexate—bone cancer	0.000221	0.000817	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—bone cancer	0.000221	0.000814	CcSEcCtD
Pergolide—Chills—Doxorubicin—bone cancer	0.00022	0.000812	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—bone cancer	0.000219	0.000808	CcSEcCtD
Pergolide—Nausea—Cisplatin—bone cancer	0.000218	0.000804	CcSEcCtD
Pergolide—Alopecia—Doxorubicin—bone cancer	0.000217	0.0008	CcSEcCtD
Pergolide—Cough—Methotrexate—bone cancer	0.000215	0.000794	CcSEcCtD
Pergolide—Ill-defined disorder—Epirubicin—bone cancer	0.000214	0.00079	CcSEcCtD
Pergolide—Convulsion—Methotrexate—bone cancer	0.000214	0.000788	CcSEcCtD
Pergolide—Anaemia—Epirubicin—bone cancer	0.000213	0.000787	CcSEcCtD
Pergolide—Agitation—Epirubicin—bone cancer	0.000212	0.000782	CcSEcCtD
Pergolide—Flatulence—Doxorubicin—bone cancer	0.00021	0.000776	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—bone cancer	0.00021	0.000774	CcSEcCtD
Pergolide—Chest pain—Methotrexate—bone cancer	0.00021	0.000774	CcSEcCtD
Pergolide—Myalgia—Methotrexate—bone cancer	0.00021	0.000774	CcSEcCtD
Pergolide—Tension—Doxorubicin—bone cancer	0.000209	0.000773	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—bone cancer	0.000209	0.000771	CcSEcCtD
Pergolide—Malaise—Epirubicin—bone cancer	0.000208	0.000768	CcSEcCtD
Pergolide—Discomfort—Methotrexate—bone cancer	0.000207	0.000765	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—bone cancer	0.000207	0.000765	CcSEcCtD
Pergolide—Vertigo—Epirubicin—bone cancer	0.000207	0.000765	CcSEcCtD
Pergolide—Syncope—Epirubicin—bone cancer	0.000207	0.000763	CcSEcCtD
Pergolide—Leukopenia—Epirubicin—bone cancer	0.000206	0.000762	CcSEcCtD
Pergolide—Back pain—Doxorubicin—bone cancer	0.000206	0.000762	CcSEcCtD
Pergolide—Palpitations—Epirubicin—bone cancer	0.000204	0.000752	CcSEcCtD
Pergolide—Confusional state—Methotrexate—bone cancer	0.000203	0.000749	CcSEcCtD
Pergolide—Loss of consciousness—Epirubicin—bone cancer	0.000203	0.000748	CcSEcCtD
Pergolide—Cough—Epirubicin—bone cancer	0.000201	0.000743	CcSEcCtD
Pergolide—Convulsion—Epirubicin—bone cancer	0.0002	0.000738	CcSEcCtD
Pergolide—Infection—Methotrexate—bone cancer	0.0002	0.000738	CcSEcCtD
Pergolide—Hypertension—Epirubicin—bone cancer	0.000199	0.000735	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—bone cancer	0.000198	0.000731	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—bone cancer	0.000197	0.000728	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—bone cancer	0.000197	0.000727	CcSEcCtD
Pergolide—Arthralgia—Epirubicin—bone cancer	0.000196	0.000725	CcSEcCtD
Pergolide—Myalgia—Epirubicin—bone cancer	0.000196	0.000725	CcSEcCtD
Pergolide—Chest pain—Epirubicin—bone cancer	0.000196	0.000725	CcSEcCtD
Pergolide—Agitation—Doxorubicin—bone cancer	0.000196	0.000724	CcSEcCtD
Pergolide—Anxiety—Epirubicin—bone cancer	0.000196	0.000722	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—bone cancer	0.000194	0.000718	CcSEcCtD
Pergolide—Discomfort—Epirubicin—bone cancer	0.000194	0.000716	CcSEcCtD
Pergolide—Malaise—Doxorubicin—bone cancer	0.000192	0.00071	CcSEcCtD
Pergolide—Dry mouth—Epirubicin—bone cancer	0.000192	0.000709	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—bone cancer	0.000192	0.000708	CcSEcCtD
Pergolide—Anorexia—Methotrexate—bone cancer	0.000192	0.000708	CcSEcCtD
Pergolide—Syncope—Doxorubicin—bone cancer	0.000191	0.000706	CcSEcCtD
Pergolide—Leukopenia—Doxorubicin—bone cancer	0.000191	0.000705	CcSEcCtD
Pergolide—Confusional state—Epirubicin—bone cancer	0.00019	0.000701	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—bone cancer	0.000189	0.000696	CcSEcCtD
Pergolide—Oedema—Epirubicin—bone cancer	0.000188	0.000695	CcSEcCtD
Pergolide—Hypotension—Methotrexate—bone cancer	0.000188	0.000694	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—bone cancer	0.000188	0.000692	CcSEcCtD
Pergolide—Infection—Epirubicin—bone cancer	0.000187	0.00069	CcSEcCtD
Pergolide—Cough—Doxorubicin—bone cancer	0.000186	0.000687	CcSEcCtD
Pergolide—Shock—Epirubicin—bone cancer	0.000185	0.000684	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—bone cancer	0.000185	0.000682	CcSEcCtD
Pergolide—Thrombocytopenia—Epirubicin—bone cancer	0.000184	0.00068	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—bone cancer	0.000184	0.00068	CcSEcCtD
Pergolide—Tachycardia—Epirubicin—bone cancer	0.000184	0.000678	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000183	0.000676	CcSEcCtD
Pergolide—Hyperhidrosis—Epirubicin—bone cancer	0.000182	0.000672	CcSEcCtD
Pergolide—Insomnia—Methotrexate—bone cancer	0.000182	0.000671	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—bone cancer	0.000182	0.000671	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—bone cancer	0.000182	0.000671	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—bone cancer	0.000182	0.000671	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—bone cancer	0.000181	0.000668	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—bone cancer	0.000181	0.000667	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—bone cancer	0.00018	0.000663	CcSEcCtD
Pergolide—Anorexia—Epirubicin—bone cancer	0.000179	0.000662	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—bone cancer	0.000179	0.000662	CcSEcCtD
Pergolide—Somnolence—Methotrexate—bone cancer	0.000179	0.00066	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—bone cancer	0.000178	0.000656	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—bone cancer	0.000177	0.000653	CcSEcCtD
Pergolide—Hypotension—Epirubicin—bone cancer	0.000176	0.000649	CcSEcCtD
Pergolide—Confusional state—Doxorubicin—bone cancer	0.000176	0.000648	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—bone cancer	0.000175	0.000645	CcSEcCtD
Pergolide—Oedema—Doxorubicin—bone cancer	0.000174	0.000643	CcSEcCtD
Pergolide—Infection—Doxorubicin—bone cancer	0.000173	0.000639	CcSEcCtD
Pergolide—Pain—Methotrexate—bone cancer	0.000172	0.000635	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000172	0.000633	CcSEcCtD
Pergolide—Shock—Doxorubicin—bone cancer	0.000171	0.000632	CcSEcCtD
Pergolide—Thrombocytopenia—Doxorubicin—bone cancer	0.000171	0.000629	CcSEcCtD
Pergolide—Insomnia—Epirubicin—bone cancer	0.00017	0.000628	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—bone cancer	0.00017	0.000627	CcSEcCtD
Pergolide—Paraesthesia—Epirubicin—bone cancer	0.000169	0.000624	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—bone cancer	0.000168	0.000621	CcSEcCtD
Pergolide—Dyspnoea—Epirubicin—bone cancer	0.000168	0.000619	CcSEcCtD
Pergolide—Somnolence—Epirubicin—bone cancer	0.000167	0.000618	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—bone cancer	0.000166	0.000613	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—bone cancer	0.000166	0.000612	CcSEcCtD
Pergolide—Dyspepsia—Epirubicin—bone cancer	0.000166	0.000612	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—bone cancer	0.000164	0.000607	CcSEcCtD
Pergolide—Decreased appetite—Epirubicin—bone cancer	0.000164	0.000604	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—bone cancer	0.000163	0.000601	CcSEcCtD
Pergolide—Constipation—Epirubicin—bone cancer	0.000161	0.000594	CcSEcCtD
Pergolide—Pain—Epirubicin—bone cancer	0.000161	0.000594	CcSEcCtD
Pergolide—Abdominal pain—Methotrexate—bone cancer	0.000159	0.000587	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—bone cancer	0.000159	0.000587	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000159	0.000586	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—bone cancer	0.000158	0.000581	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—bone cancer	0.000156	0.000577	CcSEcCtD
Pergolide—Dyspnoea—Doxorubicin—bone cancer	0.000155	0.000573	CcSEcCtD
Pergolide—Feeling abnormal—Epirubicin—bone cancer	0.000155	0.000573	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—bone cancer	0.000155	0.000571	CcSEcCtD
Pergolide—Gastrointestinal pain—Epirubicin—bone cancer	0.000154	0.000568	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—bone cancer	0.000153	0.000566	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—bone cancer	0.000151	0.000559	CcSEcCtD
Pergolide—Constipation—Doxorubicin—bone cancer	0.000149	0.00055	CcSEcCtD
Pergolide—Pain—Doxorubicin—bone cancer	0.000149	0.00055	CcSEcCtD
Pergolide—Abdominal pain—Epirubicin—bone cancer	0.000149	0.000549	CcSEcCtD
Pergolide—Body temperature increased—Epirubicin—bone cancer	0.000149	0.000549	CcSEcCtD
Pergolide—Asthenia—Methotrexate—bone cancer	0.000144	0.000533	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—bone cancer	0.000144	0.00053	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000142	0.000526	CcSEcCtD
Pergolide—Pruritus—Methotrexate—bone cancer	0.000142	0.000525	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—bone cancer	0.000138	0.000508	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—bone cancer	0.000138	0.000508	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—bone cancer	0.000138	0.000508	CcSEcCtD
Pergolide—Asthenia—Epirubicin—bone cancer	0.000135	0.000498	CcSEcCtD
Pergolide—Pruritus—Epirubicin—bone cancer	0.000133	0.000492	CcSEcCtD
Pergolide—Dizziness—Methotrexate—bone cancer	0.000133	0.000491	CcSEcCtD
Pergolide—Diarrhoea—Epirubicin—bone cancer	0.000129	0.000475	CcSEcCtD
Pergolide—Vomiting—Methotrexate—bone cancer	0.000128	0.000472	CcSEcCtD
Pergolide—Rash—Methotrexate—bone cancer	0.000127	0.000468	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—bone cancer	0.000127	0.000468	CcSEcCtD
Pergolide—Headache—Methotrexate—bone cancer	0.000126	0.000465	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—bone cancer	0.000125	0.000461	CcSEcCtD
Pergolide—Dizziness—Epirubicin—bone cancer	0.000124	0.000459	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—bone cancer	0.000123	0.000455	CcSEcCtD
Pergolide—Vomiting—Epirubicin—bone cancer	0.00012	0.000442	CcSEcCtD
Pergolide—Nausea—Methotrexate—bone cancer	0.000119	0.000441	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—bone cancer	0.000119	0.00044	CcSEcCtD
Pergolide—Rash—Epirubicin—bone cancer	0.000119	0.000438	CcSEcCtD
Pergolide—Dermatitis—Epirubicin—bone cancer	0.000119	0.000438	CcSEcCtD
Pergolide—Headache—Epirubicin—bone cancer	0.000118	0.000435	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—bone cancer	0.000115	0.000425	CcSEcCtD
Pergolide—Nausea—Epirubicin—bone cancer	0.000112	0.000413	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—bone cancer	0.000111	0.000409	CcSEcCtD
Pergolide—Rash—Doxorubicin—bone cancer	0.00011	0.000405	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—bone cancer	0.00011	0.000405	CcSEcCtD
Pergolide—Headache—Doxorubicin—bone cancer	0.000109	0.000403	CcSEcCtD
Pergolide—Nausea—Doxorubicin—bone cancer	0.000103	0.000382	CcSEcCtD
Pergolide—HTR1D—Signaling Pathways—ATF1—bone cancer	3.09e-05	0.000464	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—DHFR—bone cancer	3.07e-05	0.000461	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—GNA11—bone cancer	3.06e-05	0.000459	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—ATF1—bone cancer	3.03e-05	0.000454	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GRM1—bone cancer	3.02e-05	0.000454	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL3—bone cancer	3.01e-05	0.000453	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL3—bone cancer	2.99e-05	0.000449	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—ATF1—bone cancer	2.98e-05	0.000447	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL3—bone cancer	2.95e-05	0.000443	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL3—bone cancer	2.9e-05	0.000436	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—GNA11—bone cancer	2.88e-05	0.000433	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—GNA11—bone cancer	2.87e-05	0.000431	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—GNA11—bone cancer	2.85e-05	0.000427	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—GNA11—bone cancer	2.85e-05	0.000427	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—ATF1—bone cancer	2.84e-05	0.000427	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SMO—bone cancer	2.81e-05	0.000422	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL3—bone cancer	2.77e-05	0.000416	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SMO—bone cancer	2.71e-05	0.000407	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SMO—bone cancer	2.7e-05	0.000405	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ENO2—bone cancer	2.69e-05	0.000404	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ATF1—bone cancer	2.68e-05	0.000403	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ATF1—bone cancer	2.65e-05	0.000397	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ATF1—bone cancer	2.65e-05	0.000397	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SMO—bone cancer	2.62e-05	0.000394	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NT5C3A—bone cancer	2.61e-05	0.000393	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL3—bone cancer	2.61e-05	0.000393	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—CYP3A4—bone cancer	2.6e-05	0.000391	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SMO—bone cancer	2.58e-05	0.000388	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL3—bone cancer	2.58e-05	0.000387	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL3—bone cancer	2.58e-05	0.000387	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFBR2—bone cancer	2.58e-05	0.000387	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—GNA11—bone cancer	2.57e-05	0.000386	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFBR2—bone cancer	2.52e-05	0.000379	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—DHFR—bone cancer	2.49e-05	0.000375	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFBR2—bone cancer	2.48e-05	0.000373	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—GNA11—bone cancer	2.48e-05	0.000372	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—GNA11—bone cancer	2.47e-05	0.00037	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IGF1R—bone cancer	2.43e-05	0.000364	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—GNA11—bone cancer	2.4e-05	0.00036	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ATF1—bone cancer	2.39e-05	0.000359	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SMO—bone cancer	2.38e-05	0.000357	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IGF1R—bone cancer	2.37e-05	0.000357	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.37e-05	0.000356	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—GNA11—bone cancer	2.36e-05	0.000355	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SMO—bone cancer	2.34e-05	0.000352	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IGF1R—bone cancer	2.34e-05	0.000351	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GNA11—bone cancer	2.33e-05	0.00035	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL3—bone cancer	2.33e-05	0.00035	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ATF1—bone cancer	2.31e-05	0.000346	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—KIT—bone cancer	2.3e-05	0.000345	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SMO—bone cancer	2.29e-05	0.000344	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ATF1—bone cancer	2.29e-05	0.000344	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL3—bone cancer	2.25e-05	0.000338	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL3—bone cancer	2.24e-05	0.000336	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFBR2—bone cancer	2.24e-05	0.000336	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.23e-05	0.000335	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ATF1—bone cancer	2.23e-05	0.000335	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—GSTP1—bone cancer	2.23e-05	0.000334	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	2.21e-05	0.000331	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.21e-05	0.000331	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ATF1—bone cancer	2.2e-05	0.00033	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—GNA11—bone cancer	2.18e-05	0.000327	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL3—bone cancer	2.18e-05	0.000327	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—BRAF—bone cancer	2.16e-05	0.000324	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—GNA11—bone cancer	2.14e-05	0.000322	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL3—bone cancer	2.14e-05	0.000322	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SMO—bone cancer	2.13e-05	0.00032	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CYP3A4—bone cancer	2.11e-05	0.000317	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IGF1R—bone cancer	2.1e-05	0.000316	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.1e-05	0.000315	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—EGFR—bone cancer	2.09e-05	0.000314	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IGF1R—bone cancer	2.08e-05	0.000312	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.08e-05	0.000312	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ATF1—bone cancer	2.02e-05	0.000304	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	1.99e-05	0.000299	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ATF1—bone cancer	1.99e-05	0.000299	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL3—bone cancer	1.97e-05	0.000296	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ATF1—bone cancer	1.95e-05	0.000293	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GNA11—bone cancer	1.95e-05	0.000293	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL3—bone cancer	1.94e-05	0.000292	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFBR2—bone cancer	1.92e-05	0.000289	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFBR2—bone cancer	1.91e-05	0.000287	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL3—bone cancer	1.9e-05	0.000286	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IGF1R—bone cancer	1.87e-05	0.000281	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	1.86e-05	0.000279	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	1.83e-05	0.000275	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ATF1—bone cancer	1.81e-05	0.000272	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—TP53—bone cancer	1.81e-05	0.000272	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.81e-05	0.000272	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MDM2—bone cancer	1.81e-05	0.000272	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GSTP1—bone cancer	1.81e-05	0.000271	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IGF1R—bone cancer	1.8e-05	0.00027	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL3—bone cancer	1.77e-05	0.000265	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—KIT—bone cancer	1.76e-05	0.000264	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ENO2—bone cancer	1.75e-05	0.000263	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IGF1R—bone cancer	1.75e-05	0.000263	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IGF1R—bone cancer	1.72e-05	0.000259	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000259	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—KIT—bone cancer	1.69e-05	0.000255	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—TP53—bone cancer	1.69e-05	0.000254	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.69e-05	0.000254	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.66e-05	0.000249	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—BRAF—bone cancer	1.65e-05	0.000248	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.63e-05	0.000244	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—DHFR—bone cancer	1.63e-05	0.000244	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—BRAF—bone cancer	1.62e-05	0.000243	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—KIT—bone cancer	1.62e-05	0.000243	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.6e-05	0.000241	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—BRAF—bone cancer	1.59e-05	0.000239	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IGF1R—bone cancer	1.59e-05	0.000239	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—JUN—bone cancer	1.57e-05	0.000236	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.000236	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.56e-05	0.000235	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—EGFR—bone cancer	1.54e-05	0.000232	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.53e-05	0.00023	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MMP9—bone cancer	1.53e-05	0.00023	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—KIT—bone cancer	1.53e-05	0.000229	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—BRAF—bone cancer	1.52e-05	0.000228	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GNA11—bone cancer	1.52e-05	0.000228	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.51e-05	0.000227	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—KIT—bone cancer	1.51e-05	0.000226	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—KIT—bone cancer	1.51e-05	0.000226	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.47e-05	0.000221	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—BRAF—bone cancer	1.43e-05	0.000215	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.42e-05	0.000214	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—BRAF—bone cancer	1.42e-05	0.000212	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.42e-05	0.000212	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—EGFR—bone cancer	1.39e-05	0.000209	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MDM2—bone cancer	1.39e-05	0.000208	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000207	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TP53—bone cancer	1.37e-05	0.000206	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—EGFR—bone cancer	1.37e-05	0.000206	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.37e-05	0.000206	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—KIT—bone cancer	1.36e-05	0.000204	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MDM2—bone cancer	1.36e-05	0.000204	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MDM2—bone cancer	1.33e-05	0.0002	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—KIT—bone cancer	1.31e-05	0.000197	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—KIT—bone cancer	1.31e-05	0.000196	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.28e-05	0.000192	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MDM2—bone cancer	1.27e-05	0.000191	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—KIT—bone cancer	1.27e-05	0.000191	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—KIT—bone cancer	1.25e-05	0.000188	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.24e-05	0.000186	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—EGFR—bone cancer	1.24e-05	0.000186	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—BRAF—bone cancer	1.23e-05	0.000185	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—BRAF—bone cancer	1.23e-05	0.000184	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—JUN—bone cancer	1.2e-05	0.000181	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MDM2—bone cancer	1.2e-05	0.00018	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.2e-05	0.00018	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.19e-05	0.000179	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.19e-05	0.000179	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.19e-05	0.000178	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MDM2—bone cancer	1.19e-05	0.000178	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—JUN—bone cancer	1.18e-05	0.000177	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GSTP1—bone cancer	1.18e-05	0.000177	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.17e-05	0.000176	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MMP9—bone cancer	1.17e-05	0.000176	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—JUN—bone cancer	1.16e-05	0.000174	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.16e-05	0.000174	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PTGS2—bone cancer	1.15e-05	0.000173	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—KIT—bone cancer	1.15e-05	0.000173	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MMP9—bone cancer	1.15e-05	0.000172	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ENO2—bone cancer	1.15e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.14e-05	0.000171	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KIT—bone cancer	1.13e-05	0.00017	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MMP9—bone cancer	1.13e-05	0.00017	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KIT—bone cancer	1.11e-05	0.000167	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—JUN—bone cancer	1.11e-05	0.000166	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—BRAF—bone cancer	1.08e-05	0.000163	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MMP9—bone cancer	1.08e-05	0.000162	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.07e-05	0.000161	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—BRAF—bone cancer	1.07e-05	0.00016	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—DHFR—bone cancer	1.06e-05	0.00016	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—EGFR—bone cancer	1.05e-05	0.000158	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—JUN—bone cancer	1.04e-05	0.000157	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.04e-05	0.000157	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TP53—bone cancer	1.04e-05	0.000156	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MDM2—bone cancer	1.03e-05	0.000155	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.03e-05	0.000155	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KIT—bone cancer	1.03e-05	0.000155	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—JUN—bone cancer	1.03e-05	0.000155	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—JUN—bone cancer	1.03e-05	0.000155	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MDM2—bone cancer	1.03e-05	0.000154	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MMP9—bone cancer	1.02e-05	0.000153	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.01e-05	0.000152	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MMP9—bone cancer	1e-05	0.000151	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MMP9—bone cancer	1e-05	0.000151	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MDM2—bone cancer	1e-05	0.00015	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNA11—bone cancer	9.93e-06	0.000149	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MDM2—bone cancer	9.84e-06	0.000148	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—BRAF—bone cancer	9.69e-06	0.000146	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EGFR—bone cancer	9.47e-06	0.000142	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—EGFR—bone cancer	9.4e-06	0.000141	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—bone cancer	9.36e-06	0.000141	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—JUN—bone cancer	9.3e-06	0.00014	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EGFR—bone cancer	9.27e-06	0.000139	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EGFR—bone cancer	9.12e-06	0.000137	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MDM2—bone cancer	9.07e-06	0.000136	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—bone cancer	9.05e-06	0.000136	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—JUN—bone cancer	8.98e-06	0.000135	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—JUN—bone cancer	8.94e-06	0.000134	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MDM2—bone cancer	8.93e-06	0.000134	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MDM2—bone cancer	8.74e-06	0.000131	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—bone cancer	8.74e-06	0.000131	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EGFR—bone cancer	8.71e-06	0.000131	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—bone cancer	8.69e-06	0.000131	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—JUN—bone cancer	8.69e-06	0.000131	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—JUN—bone cancer	8.55e-06	0.000128	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—bone cancer	8.46e-06	0.000127	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—bone cancer	8.32e-06	0.000125	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EGFR—bone cancer	8.21e-06	0.000123	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MDM2—bone cancer	8.12e-06	0.000122	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—bone cancer	8.1e-06	0.000122	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—bone cancer	8.1e-06	0.000122	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—bone cancer	7.95e-06	0.000119	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—JUN—bone cancer	7.89e-06	0.000118	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—bone cancer	7.78e-06	0.000117	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—JUN—bone cancer	7.76e-06	0.000117	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—bone cancer	7.7e-06	0.000116	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—bone cancer	7.67e-06	0.000115	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—bone cancer	7.66e-06	0.000115	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—JUN—bone cancer	7.6e-06	0.000114	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—bone cancer	7.55e-06	0.000113	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—bone cancer	7.39e-06	0.000111	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—bone cancer	7.32e-06	0.00011	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—bone cancer	7.31e-06	0.00011	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—bone cancer	7.06e-06	0.000106	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—JUN—bone cancer	7.06e-06	0.000106	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—bone cancer	7.03e-06	0.000105	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—bone cancer	6.89e-06	0.000104	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—bone cancer	6.87e-06	0.000103	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—bone cancer	6.83e-06	0.000103	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—bone cancer	6.8e-06	0.000102	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—bone cancer	6.8e-06	0.000102	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—bone cancer	6.73e-06	0.000101	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—bone cancer	6.2e-06	9.31e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—bone cancer	6.14e-06	9.22e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—bone cancer	6.1e-06	9.16e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—bone cancer	6.1e-06	9.16e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—bone cancer	5.97e-06	8.97e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—bone cancer	5.93e-06	8.9e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—bone cancer	5.9e-06	8.86e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—bone cancer	5.74e-06	8.62e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—bone cancer	5.65e-06	8.48e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—bone cancer	5.55e-06	8.33e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—bone cancer	5.21e-06	7.82e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—bone cancer	5.12e-06	7.69e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—bone cancer	5.02e-06	7.53e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—bone cancer	4.66e-06	7e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—bone cancer	3.99e-06	5.99e-05	CbGpPWpGaD
